beta-Lapachone
Internal ID | b468476a-f603-4a70-bb12-8a3c6ec21bf9 |
Taxonomy | Organoheterocyclic compounds > Naphthopyrans > Naphthopyranones |
IUPAC Name | 2,2-dimethyl-3,4-dihydrobenzo[h]chromene-5,6-dione |
SMILES (Canonical) | CC1(CCC2=C(O1)C3=CC=CC=C3C(=O)C2=O)C |
SMILES (Isomeric) | CC1(CCC2=C(O1)C3=CC=CC=C3C(=O)C2=O)C |
InChI | InChI=1S/C15H14O3/c1-15(2)8-7-11-13(17)12(16)9-5-3-4-6-10(9)14(11)18-15/h3-6H,7-8H2,1-2H3 |
InChI Key | QZPQTZZNNJUOLS-UHFFFAOYSA-N |
Popularity | 714 references in papers |
Molecular Formula | C15H14O3 |
Molecular Weight | 242.27 g/mol |
Exact Mass | 242.094294304 g/mol |
Topological Polar Surface Area (TPSA) | 43.40 Ų |
XlogP | 2.20 |
Atomic LogP (AlogP) | 2.75 |
H-Bond Acceptor | 3 |
H-Bond Donor | 0 |
Rotatable Bonds | 0 |
4707-32-8 |
lapachone |
2,2-Dimethyl-3,4-dihydro-2H-benzo[h]chromene-5,6-dione |
.beta.-Lapachone |
ARQ-501 |
Lapachone, beta- |
ARQ 501 |
Beta-lap-wj |
3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-B]pyran-5,6-dione |
NSC-26326 |
There are more than 10 synonyms. If you wish to see them all click here. |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9968 | 99.68% |
Caco-2 | + | 0.7070 | 70.70% |
Blood Brain Barrier | + | 0.6000 | 60.00% |
Human oral bioavailability | + | 0.7857 | 78.57% |
Subcellular localzation | Mitochondria | 0.7994 | 79.94% |
OATP2B1 inhibitior | - | 1.0000 | 100.00% |
OATP1B1 inhibitior | + | 0.9359 | 93.59% |
OATP1B3 inhibitior | + | 0.9819 | 98.19% |
MATE1 inhibitior | - | 0.8200 | 82.00% |
OCT2 inhibitior | - | 0.7000 | 70.00% |
BSEP inhibitior | - | 0.8488 | 84.88% |
P-glycoprotein inhibitior | - | 0.9456 | 94.56% |
P-glycoprotein substrate | - | 0.9706 | 97.06% |
CYP3A4 substrate | + | 0.5132 | 51.32% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | - | 0.7755 | 77.55% |
CYP3A4 inhibition | + | 0.6108 | 61.08% |
CYP2C9 inhibition | + | 0.8628 | 86.28% |
CYP2C19 inhibition | + | 0.8736 | 87.36% |
CYP2D6 inhibition | + | 0.8308 | 83.08% |
CYP1A2 inhibition | + | 0.9107 | 91.07% |
CYP2C8 inhibition | - | 0.9390 | 93.90% |
CYP inhibitory promiscuity | + | 0.5378 | 53.78% |
UGT catelyzed | - | 0.0000 | 0.00% |
Carcinogenicity (binary) | - | 0.9318 | 93.18% |
Carcinogenicity (trinary) | Non-required | 0.5923 | 59.23% |
Eye corrosion | - | 0.9865 | 98.65% |
Eye irritation | + | 0.7012 | 70.12% |
Skin irritation | - | 0.5999 | 59.99% |
Skin corrosion | - | 0.8815 | 88.15% |
Ames mutagenesis | - | 0.7400 | 74.00% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.5480 | 54.80% |
Micronuclear | - | 0.7800 | 78.00% |
Hepatotoxicity | + | 0.6407 | 64.07% |
skin sensitisation | - | 0.5485 | 54.85% |
Respiratory toxicity | + | 0.6667 | 66.67% |
Reproductive toxicity | + | 0.8333 | 83.33% |
Mitochondrial toxicity | + | 0.6125 | 61.25% |
Nephrotoxicity | + | 0.7976 | 79.76% |
Acute Oral Toxicity (c) | III | 0.6077 | 60.77% |
Estrogen receptor binding | + | 0.8223 | 82.23% |
Androgen receptor binding | + | 0.7512 | 75.12% |
Thyroid receptor binding | - | 0.5321 | 53.21% |
Glucocorticoid receptor binding | - | 0.6142 | 61.42% |
Aromatase binding | - | 0.5461 | 54.61% |
PPAR gamma | + | 0.7218 | 72.18% |
Honey bee toxicity | - | 0.8367 | 83.67% |
Biodegradation | - | 0.6750 | 67.50% |
Crustacea aquatic toxicity | + | 0.5700 | 57.00% |
Fish aquatic toxicity | + | 0.9700 | 97.00% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL3577 | P00352 | Aldehyde dehydrogenase 1A1 |
39810.7 nM 14125.4 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL2524 | P06280 | Alpha-galactosidase A |
8912.5 nM |
Potency |
via CMAUP
|
CHEMBL2903 | P16050 | Arachidonate 15-lipoxygenase |
15848.9 nM |
Potency |
via CMAUP
|
CHEMBL1293236 | P46063 | ATP-dependent DNA helicase Q1 |
17782.8 nM 39810.7 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1293237 | P54132 | Bloom syndrome protein |
25118.9 nM 25118.9 nM 25118.9 nM |
Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP |
CHEMBL3180 | O00748 | Carboxylesterase 2 |
109 nM |
Ki |
via Super-PRED
|
CHEMBL4096 | P04637 | Cellular tumor antigen p53 |
5011.9 nM 5011.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL3356 | P05177 | Cytochrome P450 1A2 |
3981.07 nM |
AC50 |
via CMAUP
|
CHEMBL3622 | P33261 | Cytochrome P450 2C19 |
3981.07 nM |
AC50 |
via CMAUP
|
CHEMBL3397 | P11712 | Cytochrome P450 2C9 |
31622.78 nM |
AC50 |
via CMAUP
|
CHEMBL289 | P10635 | Cytochrome P450 2D6 |
15848.9 nM |
Potency |
via CMAUP
|
CHEMBL340 | P08684 | Cytochrome P450 3A4 |
15848.9 nM 15848.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1293278 | O75496 | Geminin |
31622.8 nM |
Potency |
via CMAUP
|
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha |
31622.8 nM 31622.8 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase |
100 nM 100 nM |
Ki Ki |
PMID: 25970480
via Super-PRED |
CHEMBL1293226 | B2RXH2 | Lysine-specific demethylase 4D-like |
3000 nM 3000 nM |
IC50 IC50 |
PMID: 21596573
DOI: 10.1039/C1MD00199J |
CHEMBL4040 | P28482 | MAP kinase ERK2 |
31622.8 nM 39810.7 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1293224 | P10636 | Microtubule-associated protein tau |
5011.9 nM 12589.3 nM 11220.2 nM 10000 nM 15848.9 nM |
Potency Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP via CMAUP |
CHEMBL3632452 | Q9UDY8 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 |
1200 nM 1900 nM |
IC50 IC50 |
PMID: 26496175
PMID: 26496175 |
CHEMBL5162 | Q6W5P4 | Neuropeptide S receptor |
3162.3 nM |
Potency |
via CMAUP
|
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit |
8912.5 nM 8912.5 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1293298 | Q01453 | Peripheral myelin protein 22 |
37933 nM |
Potency |
via CMAUP
|
CHEMBL1293235 | P02545 | Prelamin-A/C |
25118.9 nM 5 nM 5 nM |
Potency Potency Potency |
via CMAUP
via Super-PRED via CMAUP |
CHEMBL2842 | P42345 | Serine/threonine-protein kinase mTOR |
26121.6 nM 13091.8 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1293232 | Q16637 | Survival motor neuron protein |
15848.9 nM 25118.9 nM 7079.5 nM |
Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP |
CHEMBL1293256 | P40225 | Thrombopoietin |
1584.9 nM 1584.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1947 | P10828 | Thyroid hormone receptor beta-1 |
5011.9 nM 35481.3 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1075138 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 |
39810.7 nM |
Potency |
via CMAUP
|
CHEMBL2169736 | O95551 | Tyrosyl-DNA phosphodiesterase 2 |
970 nM 970 nM |
IC50 IC50 |
PMID: 23859074
via Super-PRED |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL2581 | P07339 | Cathepsin D | 97.30% | 98.95% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 96.32% | 95.56% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 92.34% | 91.11% |
CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 87.61% | 99.23% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 86.76% | 82.69% |
CHEMBL5697 | Q9GZT9 | Egl nine homolog 1 | 83.86% | 93.40% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 82.72% | 96.09% |
CHEMBL3401 | O75469 | Pregnane X receptor | 82.58% | 94.73% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 82.48% | 86.33% |
CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 82.39% | 97.14% |
CHEMBL2378 | P30307 | Dual specificity phosphatase Cdc25C | 82.30% | 96.67% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 81.99% | 89.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Catalpa longissima |
Handroanthus guayacan |
Handroanthus impetiginosus |
Markhamia lutea |
Markhamia stipulata |
Tectona grandis |
PubChem | 3885 |
NPASS | NPC212415 |
ChEMBL | CHEMBL15192 |
LOTUS | LTS0183748 |
wikiData | Q27089386 |